Nigel Shaw

As CEO at Exia Biomedical Nigel is responsible for the overall strategic, technical and research initiatives of the company. Founded in January 2015, Exia Biomedical's mission is "Bringing Innovations to Life"​. Exia brings together innovative people to solve difficult biomedical problems in elegant ways. The solutions Exia creates help people get the most out of life. All of Exia's products are protected by patents or pending patents. Exia's team combines deep innovative capability with world class legal and intellectual property expertise. With our founding partners having collectively over 75 years of experience in technology innovation, business management and intellectual property development, Exia is positioned from day 1 with a rich pipeline of highly innovative and well-protected solutions that creates lasting value for our customers and shareholders alike.